摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-methoxyphenyl)-but-2-enoic acid methyl ester | 940890-84-6

中文名称
——
中文别名
——
英文名称
3-(3-methoxyphenyl)-but-2-enoic acid methyl ester
英文别名
methyl 3-(3-methoxyphenyl)but-2-enoate
3-(3-methoxyphenyl)-but-2-enoic acid methyl ester化学式
CAS
940890-84-6
化学式
C12H14O3
mdl
——
分子量
206.241
InChiKey
BXGLCZGBFLRXRY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    303.6±11.0 °C(Predicted)
  • 密度:
    1.061±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-(3-methoxyphenyl)-but-2-enoic acid methyl ester4-二甲氨基吡啶lithium hydroxide monohydrate 、 palladium on activated charcoal 、 氢气盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 生成 3-(3-methoxyphenyl)-N-quinolin-3-ylbutanamide
    参考文献:
    名称:
    [EN] ANTI-HCMV COMPOSITIONS AND METHODS
    [FR] COMPOSITIONS ANTI-HCMV ET PROCÉDÉS
    摘要:
    公开号:
    WO2016077240A3
  • 作为产物:
    参考文献:
    名称:
    Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors
    摘要:
    Rho kinase is an important target implicated in a variety of cardiovascular diseases. Herein, we report the optimisation of the fragment derived ATP-competitive ROCK inhibitors 1 and 2 into lead compound 14A. The initial goal of improving ROCK-I potency relative to 1, whilst maintaining a good PK profile, was achieved through removal of the aminoisoquinoline basic centre. Lead 14A was equipotent against both ROCK-I and ROCK-II, showed good in vivo efficacy in the spontaneous hypertensive rat model, and was further optimised to demonstrate the scope for improving selectivity over PKA versus hydroxy Fasudil 3. (c) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.12.104
点击查看最新优质反应信息

文献信息

  • Isoquinoline derivatives
    申请人:Ray Christopher Peter
    公开号:US20070135479A1
    公开(公告)日:2007-06-14
    The invention relates to isoquinoline derivatives having the general Formula I wherein X is O, S or NH; Y is OH or NH 2 ; m is 0, 1 or 2; n is 1 or 2; R 1 is H, when Y is NH 2 ; or R. is H, (C 1-4 )alkyl or halogen, when Y is OH; R 2 and R 3 are independently H, (C 1-4 )alkyl or halogen; R is H or (C 1-6 )alkyl, optionally substituted with OH, (C 1-4 )-alkyloxy, (C 1-4 )alkyloxycarbonyl, (C 3-7 )cycloalkyl, which may optionally comprise a heteroatom selected from O and S, (C 6-10 )aryl, (C 6-10 )aryloxy or a 5- or 6-membered heteroaryl group comprising 1-3 heteroatoms independently selected from O, N and S, each aryl or heteroaryl group being optionally substituted with 1-3 substituents independently selected from (C 1-4 )alkyl, (C 1-4 )alkyloxy, (C 1-4 )alkylsulfonyl and halogen; or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same as well as to the use of the isoquinoline derivatives in the treatment of ROCK-I related disorders such as hypertension, atherosclerosis and glaucoma.
    本发明涉及具有通式I的异喹啉生物,其中X为O、S或NH;Y为OH或NH2;m为0、1或2;n为1或2;当Y为NH2时,R1为H;或当Y为OH时,R为H、(C1-4)烷基或卤素;R2和R3独立地为H、(C1-4)烷基或卤素;R为H或(C1-6)烷基,可选地取代为OH、(C1-4)烷氧基、(C1-4)烷氧羰基、(C3-7)环烷基,可选地包含从O和S中选择的杂原子,(C6-10)芳基、(C6-10)芳氧基或包含1-3个从O、N和S中独立选择的杂原子的5-或6成员杂芳基,每个芳基或杂芳基可选地取代为1-3个从(C1-4)烷基、(C1-4)烷氧基、(C1-4)烷基磺酰基和卤素中独立选择的取代基;或其药学上可接受的盐,以及包含相同的药物组合物,以及在治疗ROCK-I相关疾病如高血压、动脉粥样硬化和青光眼中使用异喹啉生物
  • Hypervalent Iodine(III)-induced Intramolecular Cyclization Reaction of Substituted Phenol Ethers with an Alkyl Azido Side-chain: A Novel and Efficient Synthesis of Quinone Imine Derivatives.
    作者:Yasuyuki KITA、Masahiro EGI、Makoto OHTSUBO、Toyokazu SAIKI、Akiko OKAJIMA、Takeshi TAKADA、Hirofumi TOHMA
    DOI:10.1248/cpb.47.241
    日期:——
    Novel and efficient syntheses of quinone imine ketals (2a-j) and quinone imines (4a-h) from substituted phenol ethers (1a-k) bearing an alkyl azido side-chain using the combination of hypervalent iodine(III) reagent, phenyliodine(III) bis(trifluoroacetate) (PIFA) and trimethylsilyl trifuoromethanesulfonate (TMSOTf), have been developed.
    利用高价(III)试剂,苯基(III)双(三氟乙酸酯)(PIFA)和三甲基三氟甲磺酸酯(TMSOTf)的组合,已经开发出了一种新颖且高效的合成方法,用于从带有烷基叠氮侧链的取代苯酚醚(1a-k)合成醌亚胺缩酮(2a-j)和醌亚胺(4a-h)。
  • WO2007/65916
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多